Sanofi Consumer Healthcare India Limited (NSE:SANOFICONR)

Market Cap	96.57B -11.9%
Revenue (ttm)	8.78B +21.2%
Net Income	2.40B +32.7%
EPS	104.27 +32.7%
Shares Out	23.03M
PE Ratio	40.21
Forward PE	34.71
Dividend	75.00 (1.79%)
Ex-Dividend Date	n/a

Volume	8,270
Average Volume	81,947
Open	4,307.40
Previous Close	4,357.00
Day's Range	4,160.40 - 4,335.00
52-Week Range	3,975.00 - 5,894.50
Beta	n/a
RSI	45.85
Earnings Date	Feb 25, 2026

About NSE:SANOFICONR

Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. It offers products in the allergy, physical wellness, and pain care segments under brands, such as Allegra, Combiflam, Avil, DePURA, Festal, and Novalgin NU through distributors, wholesalers, government institutions and hospitals, pharmacies, pharmacy chains, and e-commerce. The company was incorporated in 2023 and is based in Mumbai, India. Sanofi Consumer Healthcare India Limited is a subsidiary of Opella Healthcare Participations B.V.

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2023
• Employees: 583
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SANOFICONR

Financial Performance

In 2025, NSE:SANOFICONR's revenue was 8.78 billion, an increase of 21.24% compared to the previous year's 7.25 billion. Earnings were 2.40 billion, an increase of 32.65%.